For: | Geng M, Xin X, Bi LQ, Zhou LT, Liu XH. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis. World J Gastroenterol 2015; 21(38): 10732-10738 [PMID: 26478665 DOI: 10.3748/wjg.v21.i38.10732] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i38/10732.htm |
Number | Citing Articles |
1 |
Ambika Sharma, Ajay Duseja, Jyoti Parkash, Harish Changotra. Intronic region polymorphisms of autophagy gene ATG16L1 predispose individuals to Hepatitis B virus infection. Human Immunology 2025; 86(3): 111293 doi: 10.1016/j.humimm.2025.111293
|
2 |
Adolfo Contreras, Sandra Amaya Sánchez, Carolina Rodríguez‐Medina, Javier Enrique Botero. The role and impact of viruses on cancer development. Periodontology 2000 2024; 96(1): 170 doi: 10.1111/prd.12566
|
3 |
Yanbo Kou, Xiaoqing Yan, Qingya Liu, Xiao Wei, Bo Zhang, Xiangyang Li, Wei Pan, Fanyun Kong, Yugang Wang, Kuiyang Zheng, Renxian Tang. HBV upregulates AP‑1 complex subunit mu‑1 expression via the JNK pathway to promote proliferation of liver cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10291
|
4 |
Wei Hu, Dongsheng Liu, Renjie Li, Hong Qian, Wei Qiu, Qingwang Ye, Fanyun Kong. Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.913743
|
5 |
Simona John Von Freyend, Terry Kwok-Schuelein, Hans Netter, Gholamreza Haqshenas, Jean-Philippe Semblat, Christian Doerig. Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens. Pathogens 2017; 6(2): 17 doi: 10.3390/pathogens6020017
|
6 |
Rajesha Payaradka, Pushkal Sinduvadi Ramesh, Rahul Vyas, Prakash Patil, Vinay Kumar Rajendra, Mohana Kumar, Veena Shetty, Devanand Devegowda. Oncogenic viruses as etiological risk factors for head and neck cancers: An overview on prevalence, mechanism of infection and clinical relevance. Archives of Oral Biology 2022; 143: 105526 doi: 10.1016/j.archoralbio.2022.105526
|
7 |
Sergey Batskikh, Sergey Morozov, Alexey Dorofeev, Zanna Borunova, Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Vladimir Chulanov. Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer. World Journal of Gastroenterology 2022; 28(33): 4812-4822 doi: 10.3748/wjg.v28.i33.4812
|
8 |
Zhumei Zhan, Wei Yang, Wei Guo, Xin Wan, Jia Li, Ying Zhang, Bowen Wang, Xiaojing Liang, Ou Bai. HBx induces chemoresistance in diffuse large B cell lymphoma by inhibiting intrinsic apoptosis via the NF-κB/XIAP pathway. Molecular Therapy - Nucleic Acids 2024; 35(4): 102346 doi: 10.1016/j.omtn.2024.102346
|
9 |
Chiao-Fang Teng, Chun-Hui Yu, Hong-Yi Chang, Wen-Chuan Hsieh, Tzu-Hua Wu, Jia-Hui Lin, Han-Chieh Wu, Long-Bin Jeng, Ih-Jen Su. Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46891-5
|
10 |
Valerie Fako, Xin W. Wang. Hepatitis B Virus and Liver Disease. 2018; : 143 doi: 10.1007/978-981-10-4843-2_8
|
11 |
|
12 |
Lejla Mahmutović, Esma Bilajac, Altijana Hromić-Jahjefendić. Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials. Microorganisms 2021; 9(5): 1001 doi: 10.3390/microorganisms9051001
|
13 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18): 10862 doi: 10.3390/ijms231810862
|
14 |
Vanessa Meier-Stephenson, William T. R. Bremner, Chimone S. Dalton, Guido Van Marle, Carla S. Coffin, Trushar R. Patel. Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations. Viruses 2018; 10(11): 603 doi: 10.3390/v10110603
|
15 |
Julia A. Brown, Mohammed Amir, Melody Y. Zeng. Epigenetics in Organ Specific Disorders. 2023; : 181 doi: 10.1016/B978-0-12-823931-5.00002-5
|
16 |
Zuzana Vojtechova, Ruth Tachezy. The Role of miRNAs in Virus-Mediated Oncogenesis. International Journal of Molecular Sciences 2018; 19(4): 1217 doi: 10.3390/ijms19041217
|
17 |
Xiaocui Li, Delong Kong, Wei Hu, Kuiyang Zheng, Hongjuan You, Renxian Tang, Fanyun Kong. Insight into the mechanisms regulating liver cancer stem cells by hepatitis B virus X protein. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00618-y
|
18 |
Lipeng Qiu, Tao Wang, Xiuquan Xu, Yihang Wu, Qi Tang, Keping Chen. Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms. International Journal of Molecular Sciences 2017; 18(12): 2505 doi: 10.3390/ijms18122505
|
19 |
Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Setiawan, Maria Lusida, Soetjipto Soetjipto, Retno Handajani. Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomedical Reports 2019; doi: 10.3892/br.2019.1239
|
20 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers 2021; 13(10): 2454 doi: 10.3390/cancers13102454
|
21 |
Monika Mani, Shanthi Vijayaraghavan, Gopalsamy Sarangan, Ramya Barani, Priya Abraham, Padma Srikanth. Hepatitis B Virus X Protein: The X Factor in Chronic Hepatitis B Virus Disease Progression. Indian Journal of Medical Microbiology 2019; 37(3): 387 doi: 10.4103/ijmm.IJMM_19_421
|
22 |
Pranay Wal, Rohini Karuna Karan, Biplob Debnath, Himangi Vig, Charan Singh, Prasanna Shama Khandige, Vandana Sadananda, Gowrish Sadananda, Ankita Wal. Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases. 2025; : 425 doi: 10.1016/B978-0-443-28836-4.00018-4
|
23 |
Suchandrima Ghosh, Anannya Chakraborty, Soma Banerjee. Persistence of Hepatitis B Virus Infection: A Multi-Faceted Player for Hepatocarcinogenesis. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.678537
|
24 |
Hongxia Fan, Qiaoge Zhang, Xiaopei Zhao, Ping Lv, Min Liu, Hua Tang. Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Oncotarget 2017; 8(39): 65421 doi: 10.18632/oncotarget.18897
|
25 |
Dehai Wu, Hao Liang, Hao Wang, Changhu Duan, Hamza Yazdani, Jinan Zhou, Yujia Pan, Baga Shan, Zhilei Su, Jinping Wei, Tiangang Cui, Sheng Tai. Hepatitis B virus‑X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9178
|
26 |
Laura Marinela Ailioaie, Gerhard Litscher. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(19): 7150 doi: 10.3390/ijms21197150
|
27 |
Shaoli Lin, Yan-Jin Zhang. Interference of Apoptosis by Hepatitis B Virus. Viruses 2017; 9(8): 230 doi: 10.3390/v9080230
|
28 |
P. Karayiannis. Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread. Hepatology International 2017; 11(6): 500 doi: 10.1007/s12072-017-9829-7
|
29 |
Dake Zhang, Ke Zhang, Urlike Protzer, Changqing Zeng. HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00062
|
30 |
Sayed Shahabuddin Hoseini, Nai-Kong V. Cheung. Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies. Cancer Letters 2017; 399: 44 doi: 10.1016/j.canlet.2017.04.013
|
31 |
Jun‑Sheng Ni, Hao Zheng, Zhi‑Ping Huang, Yong‑Gang Hong, Yang‑Liu Ou, Yuan‑Ping Tao, Meng‑Chao Wang, Zhen‑Guang Wang, Yuan Yang, Wei‑Ping Zhou. MicroRNA‑197‑3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9848
|
32 |
Hongjuan You, Suping Qin, Fulong Zhang, Wei Hu, Xiaocui Li, Dongsheng Liu, Fanyun Kong, Xiucheng Pan, Kuiyang Zheng, Renxian Tang. Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.829923
|
33 |
Chie Ueda, Michelle Langton, Jiahua Chen, Maria-Eirini Pandelia. The HBx protein from hepatitis B virus coordinates a redox-active Fe-S cluster. Journal of Biological Chemistry 2022; 298(4): 101698 doi: 10.1016/j.jbc.2022.101698
|
34 |
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Cancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
|
35 |
Muyao Zhang, Xing Wei, Zhenfei Wang. The mechanism of HBx protein to promote the initiation and progression of hepatocellular carcinoma. Infection International 2018; 7(1): 18 doi: 10.2478/ii-2018-0010
|
36 |
Ming Han, Hongping Lu, Kai Han, Xiaoxue Yuan, Shunai Liu, Yun Wang, Jing Zhao, Pu Liang, Jun Cheng. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene. Biochemical and Biophysical Research Communications 2019; 515(3): 455 doi: 10.1016/j.bbrc.2019.05.164
|
37 |
Maura Dandri, Antonio Bertoletti, Marc Lütgehetmann. Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition. Seminars in Immunopathology 2021; 43(4): 535 doi: 10.1007/s00281-021-00864-x
|
38 |
Jun‐Fei Mou, Xiao‐Zhen Lin, He‐ling Su, Hui‐Ling Lu, Qing‐Bo Liu, Bin Liang, Xu Chen, Cheng‐Qin Liang, Xian‐Li Zhou. Anti‐hepatitis B virus activity and hepatoprotective effect of des(rhamnosyl) verbascoside from Lindernia ruellioides in vitro. Phytotherapy Research 2021; 35(8): 4555 doi: 10.1002/ptr.7159
|
39 |
Yu Jiang, Qiu-Ju Han, Jian Zhang. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World Journal of Gastroenterology 2019; 25(25): 3151-3167 doi: 10.3748/wjg.v25.i25.3151
|
40 |
Bang Manh Tran, Dustin James Flanagan, Gregor Ebert, Nadia Warner, Hoanh Tran, Theodora Fifis, Georgios Kastrappis, Christopher Christophi, Marc Pellegrini, Joseph Torresi, Toby James Phesse, Elizabeth Vincan. The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling. Cancers 2020; 12(6): 1435 doi: 10.3390/cancers12061435
|
41 |
Chengliang Zhu, Guosheng Gao, Hui Song, Fengxia Xu, Kailang Wu, Xinghui Liu. Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0340-2
|
42 |
Xiaojia Song, Siyu Tan, Zhuanchang Wu, Leiqi Xu, Zehua Wang, Yong Xu, Tixiao Wang, Chengjiang Gao, Yaoqin Gong, Xiaohong Liang, Lifen Gao, Brett T. Spear, Chunhong Ma. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR‐155 activation. International Journal of Cancer 2018; 143(12): 3120 doi: 10.1002/ijc.31595
|
43 |
Kai Zuo, Li Kong, Dong Xue, Yanyan Yang, Linlin Xie. The expression and role of lncRNA AX800134 in hepatitis B virus-related hepatocellular carcinoma. Virus Genes 2018; 54(4): 475 doi: 10.1007/s11262-018-1564-1
|
44 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
45 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
46 |
Salma Madihi, Hashim Syed, Fatiha Lazar, Abdelmajid Zyad, Abdelouaheb Benani, Haruki Komatsu. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/7027169
|
47 |
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram, Stephen K. Tyring. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention. Journal of the American Academy of Dermatology 2019; 81(1): 23 doi: 10.1016/j.jaad.2018.10.072
|
48 |
Tiziana Vescovo, Benedetta Pagni, Mauro Piacentini, Gian Maria Fimia, Manuela Antonioli. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00047
|
49 |
Fumihiro Shiromoto, Hussein H. Aly, Haruka Kudo, Koichi Watashi, Asako Murayama, Noriyuki Watanabe, Xin Zheng, Takanobu Kato, Kazuaki Chayama, Masamichi Muramatsu, Takaji Wakita. IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation. Biochemical and Biophysical Research Communications 2018; 503(3): 1854 doi: 10.1016/j.bbrc.2018.07.126
|
50 |
Kamini L. Magon, Joanna L. Parish. From infection to cancer: how DNA tumour viruses alter host cell central carbon and lipid metabolism. Open Biology 2021; 11(3) doi: 10.1098/rsob.210004
|
51 |
Krishnapriya Ramakrishnan, Sreeranjini Babu, Vineetha Shaji, Sowmya Soman, Anila Leelamma, Niyas Rehman, Rajesh Raju. Hepatitis B Virus Modulated Transcriptional Regulatory Map of Hepatic Cellular MicroRNAs. OMICS: A Journal of Integrative Biology 2023; 27(12): 581 doi: 10.1089/omi.2023.0171
|
52 |
Bo Liao, Honghao Zhou, Huifang Liang, Changhai Li. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma. International Journal of Oncology 2017; 51(5): 1449 doi: 10.3892/ijo.2017.4126
|
53 |
Cheng-Chung Wu, De-Wei Wu, Ying-Yu Lin, Po-Lin Lin, Huei Lee. Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinoma. Surgery 2018; 163(5): 1040 doi: 10.1016/j.surg.2017.11.030
|
54 |
Marie-Pier Tremblay, Victoria E. S. Armero, Andréa Allaire, Simon Boudreault, Camille Martenon-Brodeur, Mathieu Durand, Elvy Lapointe, Philippe Thibault, Maude Tremblay-Létourneau, Jean-Pierre Perreault, Michelle S. Scott, Martin Bisaillon. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. BMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-3029-z
|
55 |
|
56 |
Yushun Wan, Wei Cao, Tao Han, Sheng Ren, Jian Feng, TieLong Chen, Jun Wang, Ruth Broering, Mengji Lu, Ying Zhu. Inducible Rubicon facilitates viral replication by antagonizing interferon production. Cellular & Molecular Immunology 2017; 14(7): 607 doi: 10.1038/cmi.2017.1
|
57 |
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy 2024; 5(1): 120 doi: 10.37349/etat.2024.00209
|
58 |
Sergey Batskikh, Sergey Morozov, Dmitry Kostyushev. Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports . World Journal of Hepatology 2022; 14(7): 1512-1519 doi: 10.4254/wjh.v14.i7.1512
|
59 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 63 doi: 10.1016/B978-0-323-99283-1.00012-4
|
60 |
Caecilia H C Sukowati, Sri Jayanti, Turyadi Turyadi, David H Muljono, Claudio Tiribelli. Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now. World Journal of Gastrointestinal Oncology 2024; 16(4): 1097-1103 doi: 10.4251/wjgo.v16.i4.1097
|
61 |
Shalini Sakthivel, L. Preethi, Prudhvi Lal Bhukya. Emerging Human Viral Diseases, Volume II. 2024; : 509 doi: 10.1007/978-981-97-4480-0_19
|
62 |
Sheng-Li Yang, Quan-Guang Ren, Tao Zhang, Xiaoli Pan, Lu Wen, Jian-Li Hu, Chao Yu, Qian-Jin He. Hepatitis B virus X protein and hypoxia-inducible factor-1α stimulate Notch gene expression in liver cancer cells. Oncology Reports 2017; 37(1): 348 doi: 10.3892/or.2016.5211
|
63 |
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
|